Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2026-01-16 @ 3:34 PM
Study NCT ID:
NCT01710267
Status:
COMPLETED
Last Update Posted:
2015-04-01
First Post:
2012-10-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rivaroxaban Laboratory Monitoring in Switzerland 2: Therapeutic Dose (RivaMoS 2)
Sponsor:
Prof. Dr. Dr. med. Walter A. Wuillemin, MD, PhD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-03
Start Date Type:
None
Primary Completion Date:
2014-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-12
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-17
First Submit QC Date:
None
Study First Post Date:
2012-10-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-31
Last Update Post Date:
2015-04-01
Last Update Post Date Type:
ESTIMATED